PT518 – The EMBARK Model of Psychedelic Therapy, with Alex Belser, Ph.D. & Bill Brennan, Ph.D.
Psychedelics Today4 Kesä 2024

PT518 – The EMBARK Model of Psychedelic Therapy, with Alex Belser, Ph.D. & Bill Brennan, Ph.D.

In this episode, Kyle interviews Alex Belser, Ph.D. and Bill Brennan, Ph.D.: psychologists, psychedelic researchers, authors, and co-creators of the EMBARK model, a framework for psychedelic therapy.

When Belser and Brennan worked together at Cybin, they canvassed the field of psychedelic research and saw very little reporting (if any) of the manuals researchers were using, so they created the EMBARK model as a "big tent" framework – a way to understand what patients were going through from the perspective of six different clinical domains, where the clinician can go deeper into whichever domain is needed based on their specific skill sets. The EMBARK model has been used in two randomized controlled trials to date, and its corresponding book, EMBARK Psychedelic Therapy for Depression: A New Approach for the Whole Person (co-authored by Belser and Brennan), was released in April.

They discuss:

  • The six domains and four ethical care cornerstones that make up EMBARK, as well as the many proposed change mechanisms that come into play
  • Concerns over facilitators stepping aside and letting the medicine do the work: How much of a factor is someone's presence in the room?
  • How much smaller, "little t" traumas can affect people – trauma doesn't always come from a single hallmark event
  • The need for facilitators to be trained well (and trauma-informed), as it's nearly impossible to tell when an adverse outcome is coming

and more!

For links, head to the show notes page.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(774)

PT528 – Chronic Pain and Inducing Neuroplasticity With Psychedelics, with Lynn Watkins, Retired USAF, and C.J. Spotswood, PMHNP

PT528 – Chronic Pain and Inducing Neuroplasticity With Psychedelics, with Lynn Watkins, Retired USAF, and C.J. Spotswood, PMHNP

In this episode, Joe and REMAP Therapeutics Founder, Court Wing, host Lynn Watkins: medically retired USAF JAG & Ops Resource Mgmt Specialist; and C.J. Spotswood, PMHNP: principle psychiatric clinicia...

9 Heinä 20241h 8min

PT527 – Symptoms as Signals: Trauma and the Role of Inner Healing Intelligence, with Casey Paleos, MD

PT527 – Symptoms as Signals: Trauma and the Role of Inner Healing Intelligence, with Casey Paleos, MD

In this episode of Vital Psychedelic Conversations, David interviews Casey Paleos, MD: Vital instructor, researcher, psychiatrist with a private practice offering ketamine infusion therapy and KAP, an...

5 Heinä 20241h 19min

PT526 – Transforming Trauma: Community, Connection, and the Healing Power of Vulnerability, with Peter A. Levine, Ph.D.

PT526 – Transforming Trauma: Community, Connection, and the Healing Power of Vulnerability, with Peter A. Levine, Ph.D.

In this episode, Kyle interviews Peter A. Levine, Ph.D.: developer of Somatic Experiencing®, educator, and author of several best-selling books on trauma. His most recent book, An Autobiography of Tra...

2 Heinä 20241h 16min

PT525 – Women and Psychedelics: History's Untold Stories, with Erika Dyck

PT525 – Women and Psychedelics: History's Untold Stories, with Erika Dyck

In this episode of Vital Psychedelic Conversations, Johanna interviews Erika Dyck: author, professor, historian, Vital instructor, and research chair in the History of Health & Social Justice at the U...

28 Kesä 20241h 6min

PT524 – Building a Unified Psychedelic Future: Ethics, Standards, and a Path to Affordable Access, with Lia Mix, LMFT, CPTR

PT524 – Building a Unified Psychedelic Future: Ethics, Standards, and a Path to Affordable Access, with Lia Mix, LMFT, CPTR

In this episode, Joe interviews Lia Mix, LMFT, CPTR: founder and CEO of Delphi, a consulting firm dedicated to the healthy growth of the psychedelic movement. After many years of working in community ...

25 Kesä 20241h 8min

PT523 – Self-Care, Destabilization, and the Holistic Nature of Psychedelics, with Kaitlin Roberson & Dr. Michele Cox, DO

PT523 – Self-Care, Destabilization, and the Holistic Nature of Psychedelics, with Kaitlin Roberson & Dr. Michele Cox, DO

In this episode of Vital Psychedelic Conversations, David interviews Kaitlin Roberson: Vital graduate and co-founder and CEO of Cacti Therapeutics, a psychedelic biotech company developing novel thera...

21 Kesä 20241h 17min

PT522 – An Inside look at the FDA and Early Drug Development, with Dr. Amanda Holley

PT522 – An Inside look at the FDA and Early Drug Development, with Dr. Amanda Holley

In this episode, Joe interviews Dr. Amanda Holley: pharmacologist and regulatory consultant in nonclinical drug development, and previously a nonclinical pharmacology/toxicology reviewer at the FDA. W...

18 Kesä 20241h 3min

PT521 – Community, Group Process, and Co-Creation: How to Build a Successful Retreat, with Alice Dommert & Kara Tremain, ACC

PT521 – Community, Group Process, and Co-Creation: How to Build a Successful Retreat, with Alice Dommert & Kara Tremain, ACC

In this episode of Vital Psychedelic Conversations, Kyle interviews two Vital graduates: Alice Dommert: certified breathwork facilitator and co-founder of retreat company, The Infinite Center; and Kar...

14 Kesä 20241h 11min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-poliisin-mieli
tiedekulma-podcast
utelias-mieli
rss-duodecim-lehti
rss-totuuden-liepeilla
university-of-eastern-finland
docemilia
filocast-filosofian-perusteet
rss-bios-podcast
rss-duokkari-ekstra
rss-laakaripodi
rss-astetta-parempi-elama-podcast
rss-tiedetta-vai-tarinaa
rss-ilmasto-kriisissa
rss-ylistys-elaimille